Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Morpholino oligomer-induced dystrophin isoforms to map the functional domains in the dystrophin protein

Li, D., Adams, A.M., Johnsen, R.D., Fletcher, S. and Wilton, S.D. (2020) Morpholino oligomer-induced dystrophin isoforms to map the functional domains in the dystrophin protein. Molecular Therapy - Nucleic Acids, 22 . pp. 263-272.

PDF - Published Version
Download (4MB) | Preview
Free to read:
*No subscription required


Dystrophin plays a crucial role in maintaining sarcolemma stability during muscle contractions, and mutations that prevent the expression of a functional protein cause Duchenne muscular dystrophy. Antisense oligonucleotide-mediated manipulation of premessenger RNA splicing to by-pass Duchenne-causing mutations and restore functional dystrophin expression has entered the clinic for the most common DMD mutations. The rationale of “exon skipping” is based upon genotype-phenotype correlations observed in Becker muscular dystrophy, a milder allelic disorder generally characterised by in-frame deletions and internally truncated but semi-functional dystrophin isoforms. However, there is lack of genotype-phenotype correlations downstream of DMD exon 55, as deletions in this region are rare and most single exon deletions would disrupt the reading frame. Consequently, the amenability of mutations in this region of the DMD gene to exon skipping strategies remains unknown. Here, we induced “Becker muscular dystrophy-like” in-frame dystrophin isoforms in vivo by intraperitoneal injection of peptide-conjugated phosphorodiamidate morpholino oligomers targeting selected exons. The dystrophin isoform encoded by the transcript lacking exons 56+57 appears to be more functional than that encoded by the 58+59-deleted transcript, as determined by higher dystrophin expression, stabilized β- dystroglycan, and less severe dystrophic pathology, indicating some potential for the strategy to address Duchenne-causing mutations affecting these exons.

Item Type: Journal Article
Murdoch Affiliation(s): Centre for Molecular Medicine and Innovative Therapeutics (CMMIT)
Publisher: Elsevier
Copyright: © 2020 The Authors
Item Control Page Item Control Page


Downloads per month over past year